DGAT-1 inhibitor 2

Cat. No.: 0225LY-0719

Appearance: Solid

Purity: ≥98%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: DGAT-1 inhibitor 2 is an effective anti-obesity agent that targets acyl-CoA: diacylglycerol acyltransferase 1, the enzyme responsible for the final stage of triglyceride synthesis; inhibiting this enzyme is a key strategy for treating type 2 diabetes and obesity.

Synonym: 942999-61-3; DGAT1 Inhibitor 2; 2-[4-[4-(4-amino-7,7-dimethylpyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-1-bicyclo[2.2.2]octanyl]acetic acid; Bicyclo[2.2.2]octane-1-acetic acid, 4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-; {4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]bicyclo[2.2.2]oct-1-yl}acetic Acid; {4-[4-(4-Amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]bicyclo[2.2.2]octan-1-yl}acetic acid; 2-[4-(4-{4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl}phenyl)bicyclo[2.2.2]octan-1-yl]acetic acid

CAS No.: 942999-61-3

Compound CID: 16202164

Formula: C₂₄H₂₈N₄O₃

Formula Weight: 420.5

Specification

Relative Density: 1.39 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: DGAT-1 inhibitor 2 can be used in metabolic research to study the inhibition of triglyceride synthesis and its impact on obesity and fatty liver.